BioCryst Pharmaceuticals Inc at H C Wainwright Global Investment Conference (Virtual) - On-Demand Transcript
Hello, everyone. I'm Andrew Fein. I'm 1 of the biotechnology analysts at H.C. Wainwright. It's my pleasure for the next company -- excuse me, to introduce the next company speaking today will be BioCryst Pharmaceuticals. I've the whole gang here for us. So hopefully, we can cover a lot of topics. Maybe the best place to start just handing it off to the company's CEO, Jon Stonehouse, to kind of lay the landscape in terms of where things are and what we can kind of expect in the next few quarters from the company.
Sure. And, Andy, thanks for inviting us to your health care conference. I wish we were doing this face-to-face, but I guess we won't do it for now. So let me quickly say that with me today is Charlie Gayer, our Chief Commercial Officer; Anthony Doyle, our Chief Financial Officer; Bill Sheridan, our Chief Medical Officer; and John Bluth, our
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
